These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 7049077)

  • 1. Effects of clofazimine alone or combined with dapsone on neutrophil and lymphocyte functions in normal individuals and patients with lepromatous leprosy.
    van Rensburg CE; Gatner EM; Imkamp FM; Anderson R
    Antimicrob Agents Chemother; 1982 May; 21(5):693-7. PubMed ID: 7049077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and in vivo effects of dapsone on neutrophil and lymphocyte functions in normal individuals and patients with lepromatous leprosy.
    Anderson R; Gatner EM; van Rensburg CE; Grabow G; Imkamp FM; Kok SK; van Rensburg AJ
    Antimicrob Agents Chemother; 1981 Apr; 19(4):495-503. PubMed ID: 6264848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of ketoconazole on cellular and humoral immune functions.
    van Rensburg CE; Anderson R; Jooné G; van der Merwe MF; Eftychis HA
    J Antimicrob Chemother; 1983 Jan; 11(1):49-55. PubMed ID: 6298175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of sulfamethoxazole and trimethoprim on human neutrophil and lymphocyte functions in vitro: in vivo effects of co-trimoxazole.
    Anderson R; Grabow G; Oosthuizen R; Theron A; Van Rensburg AJ
    Antimicrob Agents Chemother; 1980 Mar; 17(3):322-6. PubMed ID: 7425598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clofazimine-mediated regulation of human polymorphonuclear leukocyte migration by pro-oxidative inactivation of both leukoattractants and cellular migratory responsiveness.
    Anderson R; Lukey P; Van Rensburg C; Dippenaar U
    Int J Immunopharmacol; 1986; 8(6):605-20. PubMed ID: 3793326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement by clofazimine and inhibition by dapsone of production of prostaglandin E2 by human polymorphonuclear leukocytes in vitro.
    Anderson R
    Antimicrob Agents Chemother; 1985 Feb; 27(2):257-62. PubMed ID: 3857019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical trial of ofloxacin alone and in combination with dapsone plus clofazimine for treatment of lepromatous leprosy.
    Ji B; Perani EG; Petinom C; N'Deli L; Grosset JH
    Antimicrob Agents Chemother; 1994 Apr; 38(4):662-7. PubMed ID: 8031029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical trial with clofazimine in leprosy.
    Ganapati R; Dongre VV
    Lepr India; 1976 Oct; 48(4 Suppl):703-8. PubMed ID: 1026807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ascorbate-mediated stimulation of neutrophil motility and lymphocyte transformation by inhibition of the peroxidase/H2O2/halide system in vitro and in vivo.
    Anderson R
    Am J Clin Nutr; 1981 Sep; 34(9):1906-11. PubMed ID: 7282616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Once monthly rifampicin (1200 mg) plus daily dapsone (100 mg) and clofazimine (100 mg) in the initial treatment of lepromatous leprosy.
    Chandorkar AG; Burte NP; Gade RK; Bulakh PM
    Indian J Lepr; 1984; 56(1):63-70. PubMed ID: 6384381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multicentre controlled comparative trial of clofazimine and dapsone in low dosages.
    Ahrens TF; Pettit JH; Ridley DS; Glaus L
    Lepr Rev; 1975 Dec; 46(4):287-96. PubMed ID: 1107728
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of metronidazole on certain functions of human blood neutrophils and lymphocytes.
    Anderson R; Oosthuizen R; Maritz C; Theron A; Van Rensburg AJ
    S Afr Med J; 1979 Apr; 55(15):593-6. PubMed ID: 462263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transformation from lepromatous to borderline leprosy under clofazimine therapy.
    Mahapatra SB; Ramu G
    Lepr India; 1976 Apr; 48(2):172-6. PubMed ID: 1022964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minocycline is effective and cosmetically preferred to clofazimine by leprosy patients in New York.
    Levis WR; Spencer TI; Ladizinski B
    J Drugs Dermatol; 2010 Aug; 9(8):906. PubMed ID: 20684139
    [No Abstract]   [Full Text] [Related]  

  • 15. Dapsone syndrome--a case report.
    Khare AK; Bansal NK; Meena HS
    Indian J Lepr; 1987; 59(1):106-9. PubMed ID: 3611856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of multidrug therapy with rifampicin, clofazimine and D.D.S. in multibacillary leprosy cases.
    Kundu SK; Hazra SK; Chaudhury S; Chatterjee B
    Indian J Lepr; 1984; 56(1):78-85. PubMed ID: 6548246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clofazimine in the treatment of dapsone resistant leprosy.
    Taylor PM; Alexander R
    Lepr India; 1976 Oct; 48(4 Suppl):709-12. PubMed ID: 800234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dapsone syndrome in Vanuatu: a high incidence during multidrug treatment (MDT) of leprosy.
    Reeve PA; Ala J; Hall JJ
    J Trop Med Hyg; 1992 Aug; 95(4):266-70. PubMed ID: 1386634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A retrospective study of the effect of modified multi-drug therapy in Nepali leprosy patients following the development of adverse effects due to dapsone.
    Sapkota BR; Shrestha K; Pandey B; Walker SL
    Lepr Rev; 2008 Dec; 79(4):425-8. PubMed ID: 19274989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haematological and biochemical alterations in leprosy patients already treated with dapsone and MDT.
    Queiroz RH; Melchior Júnior E; de Souza AM; Gouveia E; Barbosa JC; de Carvalho D
    Pharm Acta Helv; 1997 Sep; 72(4):209-13. PubMed ID: 9372643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.